Market research
1X8.F Creso Pharma Limited
F EUR Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 16B
- P/E ratio
- 11.94
- Analyst target
- Not available
- Dividend yield
- 1.6%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 1X8.F discussion.
5 years, 5 months ago
Creso Pharma Limited is currently in a long term downtrend where the price is trading 26.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 26.2.
Finally, its free cash flow fell by 20.1% to $-3M since the same quarter in the previous year.
Based on the above factors, Creso Pharma Limited gets an overall score of 1/5.